Healthcare -
Biotechnology - NASDAQ - US
$ 2.45
6.52 %
$ 170 M
Market Cap
-0.79
P/E
IKT - REVENUE
Revenue IKT - Inhibikase Therapeutics, Inc.
260 K
LAST VALUE
-71.01%
2 YEAR CAGR
-42.21%
5 YEAR CAGR
0.00%
10 YEAR CAGR